Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Synthetic Reagents Improve Sensitivity and Specificity of Immunoassays

By LabMedica International staff writers
Posted on 30 Dec 2009
Synthetic reagents enhance sensitivity and specificity in enzyme-linked immunosorbent assays (ELISAs), rapid tests, and other immunoassays by decreasing nonspecific binding and stabilizing antibody-antigen complexes.

The wholly synthetic biocompatible bovine serum albumin (BSA) substitutes provide more effective blocking than BSA and generally improve overall signal to noise. More...
In addition, because they are synthetic, the reagents do not require any special handling normally associated with animal-derived materials and offer consistent lot-to-lot performance.

Supplied by B-Bridge International (Mountain View, CA, USA), the Biolipidure reagents are not susceptible to degradation and protease digestion, because they are nonbiological polymers. These polymers are extremely stable at high temperature and over multiple freeze-thaw cycles. This characteristic increases the robustness of reagents containing these compounds, enables antibodies to remain functional longer, and extends the shelf life of immunoassay kits.

The basic Biolipidure monomer contains a functional side group, which introduces some variability to the different polymers. The specific molecular weights, hydrophilicity-hydrophobicity, and ionic properties of the side groups produce a range of Biolipidure reagents whose secondary characteristics vary.

Because they are completely synthetic, Biolipidure reagents do not require any special handling normally associated with animal-derived materials and there is negligible lot-to-lot variation. There is no need to optimize for each lot and purchase large amounts of a single lot to obtain consistent results.

Related Links:

B-Bridge International


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.